Hai Sheng Pharmaceutical: Shareholder Wang Xiaoqing plans to reduce holdings by 1.8%

Haisheng Pharmaceutical announced that shareholder Wang Xiaoqing holds 24.5046% of the shares, with a total of 24.5046 million shares. The shareholder plans to reduce his holdings by no more than 1.8%, or 1.8 million shares, through centralized bidding or block trading within three months after the disclosure date of the announcement. The source of the shares to be reduced was obtained before the listing on the North Exchange, and the reason for the reduction is for personal financial arrangements. No single entity's centralized bidding reduction plan will exceed 1% of the total company shares within three months.